J. Hosenpud, L. Bennett, B. Keck, B. Fiol, M. Boucek et al., The Registry of the International Society for Heart and Lung Transplantation: Fifteenth Official Report???1998, J Heart Lung Transplant, vol.17, pp.656-668, 1998.
DOI : 10.1007/978-0-585-29191-8_6

. Fritsche, Impact of cyclosporine on the development of immunosuppressive therapy, Transplantation Proceedings, vol.36, issue.2, pp.130-134, 2003.
DOI : 10.1016/j.transproceed.2003.12.038

D. Taylor, J. Stehlik, L. Edwards, A. P. Christie, J. Dobbels et al., Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report???2009, The Journal of Heart and Lung Transplantation, vol.28, issue.10, pp.1007-1022, 2009.
DOI : 10.1016/j.healun.2009.08.014

D. Goldstein, N. Zuech, V. Sehgal, A. Weinberg, R. Drusin et al., CYCLOSPORINE-ASSOCIATED END-STAGE NEPHROPATHY AFTER CARDIAC TRANSPLANTATION, Transplantation, vol.63, issue.5, pp.664-668, 1997.
DOI : 10.1097/00007890-199703150-00009

A. Ojo, P. Held, F. Port, R. Wolfe, A. Leichtman et al., Chronic Renal Failure after Transplantation of a Nonrenal Organ, New England Journal of Medicine, vol.349, issue.10, pp.931-940, 2003.
DOI : 10.1056/NEJMoa021744

J. Pattison, J. Petersen, P. Kuo, V. Valantine, R. Robbins et al., The incidence of renal failure in one hundred consecutive heart-lung transplant recipients, American Journal of Kidney Diseases, vol.26, issue.4, pp.643-648, 1995.
DOI : 10.1016/0272-6386(95)90602-9

J. Kobashigawa, L. Miller, D. Renlund, R. Mentzer, E. Alderman et al., A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1, Mycophenolate Mofetil Investigators, pp.507-515, 1998.
DOI : 10.1097/00007890-199808270-00016

H. Ekberg, C. Bernasconi, H. Tedesco-silva, S. Vítko, C. Hugo et al., Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation, American Journal of Transplantation, vol.3, issue.Suppl 1, pp.1876-1885, 2009.
DOI : 10.1111/j.1600-6143.2009.02726.x

R. Gaston, B. Kaplan, T. Shah, D. Cibrik, L. Shaw et al., Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial, American Journal of Transplantation, vol.27, issue.2 Suppl, pp.1607-1619, 2009.
DOI : 10.1111/j.1600-6143.2009.02668.x

URL : http://deepblue.lib.umich.edu/bitstream/2027.42/74911/1/j.1600-6143.2009.02668.x.pdf

D. Cohen and F. Vincenti, A comparative open label study to evaluate graft function in de novo renal allograft recipients treated with reduced dose or standard dose cyclosporine in combination with sirolimus and corticosteroids, Am J Transplant, issue.5, p.465, 2003.

R. De-sévaux, P. Gregoor, R. Hené, A. Hoitsma, P. Vos et al., A controlled trial comparing two doses of cyclosporine in conjunction with mycophenolate mofetil and corticosteroids, J Am Soc Nephrol, vol.12, pp.1750-1757, 2001.

T. Gonwa, D. Hricik, K. Brinker, J. Grinyo, and F. Schena, Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination1, 2, Transplantation, vol.74, issue.11, pp.1560-1567, 2002.
DOI : 10.1097/00007890-200212150-00013

B. Kahan, B. Julian, M. Pescovitz, Y. Vanrenterghem, and J. Neylan, SIROLIMUS REDUCES THE INCIDENCE OF ACUTE REJECTION EPISODES DESPITE LOWER CYCLOSPORINE DOSES IN CAUCASIAN RECIPIENTS OF MISMATCHED PRIMARY RENAL ALLOGRAFTS: A PHASE II TRIAL1, Transplantation, vol.68, issue.10, pp.1526-1532, 1999.
DOI : 10.1097/00007890-199911270-00016

F. Muhlbacher and L. Paczek, An open-label study to evaluate the efficacy and safety of cyclosporine reductionin de novo renal allograft recipients http://www.trialsjournal.com/content/13/1/231 receiving sirolimus: a dose comparative study, Am J Transplant, vol.3, p.238, 2002.

J. Kobashigawa, L. Miller, S. Russell, G. Ewald, M. Zucker et al., Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report, American Journal of Transplantation, vol.2, issue.3, pp.1377-1386, 2006.
DOI : 10.1016/S0955-470X(03)00022-3

S. Stewart, G. Winters, M. Fishbein, H. Tazelaar, J. Kobashigawa et al., Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection, The Journal of Heart and Lung Transplantation, vol.24, issue.11, pp.1710-1720, 2005.
DOI : 10.1016/j.healun.2005.03.019

H. Ekberg, The use of daclizumab and mycophenolate mofetil in combination with corticosteroids and cyclosporing (low dose versus low dose followed by withdrawal) to optimize renal function in recipients of renal allografts [poster presentation, Vienna, Austria: International Conference of the Transplantation Society (ICTS), 2004.

A. Nationale-d, Accréditation et d'Evaluation en Santé: [Diagnosis of adult chronic kidney failure, Diabetes Metab, vol.29, pp.315-324, 2003.

C. Couchoud, N. Pozet, M. Labeeuw, and C. Pouteil-noble, Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment, Kidney International, vol.55, issue.5, pp.1878-1884, 1999.
DOI : 10.1046/j.1523-1755.1999.00411.x

T. Van-gelder, Mycophenolate Blood Level Monitoring: Recent Progress, American Journal of Transplantation, vol.14, issue.Suppl, pp.1495-1499, 2009.
DOI : 10.1111/j.1600-6143.2009.02678.x

M. Hertz, P. Aurora, C. Benden, J. Christie, F. Dobbels et al., Scientific Registry of the International Society for Heart and Lung Transplantation: Introduction to The 2011 Annual Reports, The Journal of Heart and Lung Transplantation, vol.30, issue.10, pp.1071-1132, 2011.
DOI : 10.1016/j.healun.2011.08.002